期刊
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
卷 28, 期 6, 页码 585-590出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.urolonc.2009.06.010
关键词
Stem cells; Urology
资金
- MOGA/COSA/Roche HOTT Fellowship
- RACP CSL Fellowship
- RACP Australia Post Fellowship
- Edita-Viola Reid Scholarship
- Victorian Cancer Agency
There is evolving evidence for the so-called cancer stem cell (CSC) hypothesis, which holds that intra-tumoral heterogeneity in urologic malignancies is hierarchical and that not all cells have the ability to proliferate indefinitely and to generate metastases. This has far-reaching implications for research and the clinical management of urologic malignancies. In this review, we outline the tenets and implications of the CSC hypothesis, summarize existing evidence for CSCs in urologic malignancies, suggest research directions that may better dissect intra-tumoral heterogeneity in urologic cancers, and outline novel therapeutic modalities implied by the CSC hypothesis. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据